Quipt Home Medical Corp. (Nasdaq: QIPT) has cleared the final major hurdle as it transitions from being a publicly held to a privately held company.
A March 5 press release announced that the end-to-end respiratory care provider had received a final order from the Supreme Court of British Columbia regarding the effort of affiliates of Kingswood Capital Management and Forager Capital Management to acquire all issued and outstanding shares of common Quipt stock at the price of $3.65 U.S. per share.
“The final order was the final substantive court approval required prior to the closing of the arrangement,” the Quipt announcement said. “Assuming all other terms and conditions to the arrangement are satisfied, it is expected that the arrangement will be completed by March 16, 2026.”
Quipt will leave the Toronto Stock Exchange and Nasdaq upon being acquired.
The company said it “seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility and other chronic health conditions. The primary business objective of [Quipt] is to offer a broader range of services to patients in need of in-home monitoring and chronic disease management.”
